# Oruka Therapeutics (ORKA) — Analyst Forecast

ORKA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/orka/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 14 | 0 | 0 | 14 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $120.00 | $159.00 | $200.00 | 4 |

Last price $73.87 (as of Oct 15, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 24, 2026 | HC Wainwright & Co. | Maintained | Buy | $120.00 |
| Sep 24, 2026 | Wedbush | Maintained | Outperform | $165.00 |
| Sep 3, 2026 | HC Wainwright & Co. | Maintained | Buy | $120.00 |
| Aug 11, 2026 | BTIG | Maintained | Buy | $151.00 |
| Aug 11, 2026 | Wedbush | Maintained | Outperform | $165.00 |
| Aug 11, 2026 | Guggenheim | Maintained | Buy | $200.00 |
| Aug 3, 2026 | HC Wainwright & Co. | Maintained | Buy | $120.00 |
| Jul 13, 2026 | BTIG | Maintained | Buy | $151.00 |
| Jul 1, 2026 | UBS | Maintained | Buy | $130.00 |
| Jun 23, 2026 | HC Wainwright & Co. | Maintained | Buy | $120.00 |
| May 18, 2026 | HC Wainwright & Co. | Maintained | Buy | $120.00 |
| May 14, 2026 | BTIG | Maintained | Buy | $151.00 |
| Apr 29, 2026 | HC Wainwright & Co. | Maintained | Buy | $120.00 |
| Apr 28, 2026 | Barclays | Maintained | Overweight | $160.00 |
| Apr 28, 2026 | UBS | Maintained | Buy | $100.00 |
| Apr 27, 2026 | BTIG | Maintained | Buy | $151.00 |
| Apr 15, 2026 | Wedbush | Maintained | Outperform | $85.00 |
| Apr 13, 2026 | HC Wainwright & Co. | Maintained | Buy | $70.00 |
| Apr 13, 2026 | BTIG | Maintained | Buy | $78.00 |
| Apr 13, 2026 | Guggenheim | Maintained | Buy | $125.00 |

## Frequently Asked Questions

### What is the price target for ORKA stock?

The average 12-month analyst price target for Oruka Therapeutics (ORKA) is $159.00, with a high estimate of $200.00 and a low of $120.00, across 4 analysts.

### Is ORKA a buy, sell, or hold?

Analysts covering Oruka Therapeutics currently average a Buy rating: 14 buy, 0 hold and 0 sell, from 14 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for ORKA?

The average price target of $159.00 implies 115.24% upside from the last price of $73.87.

### What is the latest analyst rating on ORKA?

On Sep 24, 2026, HC Wainwright & Co. maintained Oruka Therapeutics at Buy with a price target of $120.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).